$CACC

CREDIT ACCEPTANCE CORP

No enriched coverage for $CACC in the last 7 days.

No SEC Form 4 filings for $CACC in the last 30 days.

Med

Credit Acceptance Corp stock (US12468P1049): Shares near recent highs after May trading update

Credit Acceptance Corp shares were trading near recent highs in early May 2026, reaching around $507, attracting attention from US investors focusing on consumer credit and used-car finance. The company's performance is driven by the volume and profitability of its auto finance activity, making it sensitive to changes in household borrowing conditions and broader consumer stress. Its stock offers insight into how lower- and middle-income borrowers are managing car payments in a higher-rate environment, making it a key indicator for the US auto market's lending conditions.

Affiliate sale: CACC (NASDAQ: CACC) notices sale of 3,500 shares

A Form 144 filing by an affiliate of Credit Acceptance Corp (CACC) indicates a proposed sale of 3,500 common shares derived from an option, scheduled for April 21, 2026. The filing also details multiple past cash sales by Daniel A. Ulatowski and the D.& B. Ulatowski Living Trust from January to April 2026, including several large-volume trades. Analysts consider the filing to have a neutral impact, viewing the transactions as routine affiliate dispositions that do not alter corporate governance or capital structure.

CACC (NASDAQ: CACC) Form 144 shows 4,062-share sale; Rummler sold 8,126 shares

A Form 144 filing for Credit Acceptance Corporation (CACC) indicates a proposed sale of 4,062 shares stemming from options granted on December 30, 2020, with a listed sale date of April 17, 2026. The filing also reports previous sales by Wendy Rummler, totaling 8,126 shares across two transactions in January and February 2026 for a combined value of approximately $4 million. The document provides details on the regulatory requirements for Form 144 and includes key figures related to the proposed and past sales.